Belvedere Trading
ENFN

Belvedere Trading’s Enfusion, Inc. ENFN Stock Holding History

Belvedere Trading’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,600
Closed -$264K – 1085
2024
Q4 		$264K Buy
+25,600
New +$247K ﹤0.01% 364
2023
Q3 		– Sell
-6,800
Closed -$76.3K – 1021
2023
Q2 		$76.3K Buy
+6,800
New +$60.3K ﹤0.01% 476

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Belvedere Trading's ENFN Position: Q1 2025 in Review

Belvedere Trading sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 3,230 shares — an estimated $33.3K sold.

Belvedere Trading first reported a position in ENFN in Q2 2023 and held it in 3 quarters. The position peaked at $593K in Q2 2023. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Belvedere Trading reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Belvedere Trading sold 3,230 Enfusion, Inc. shares in Q1 2025, an estimated $33.3K.
  • Belvedere Trading first reported a position in Enfusion, Inc. in Q2 2023 and held it in 3 quarters.
  • Belvedere Trading's Enfusion, Inc. position peaked at $593K in Q2 2023.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Belvedere Trading's 13F filing for Q1 2025, filed 9 May 2025.